A biomaterial is any material designed to interact with living tissue for a medical purpose. That purpose can be as simple as a metal plate holding a broken bone together or as complex as a dissolving scaffold that guides your body to grow new cartilage. The formal definition, refined over decades of debate, describes it as “a material designed to take a form that can direct, through interactions with living systems, the course of any therapeutic or diagnostic procedure.” The global biomaterials market was valued at roughly $237 billion in 2025 and is projected to more than triple by 2033, reflecting how central these materials have become to modern medicine.
How the Concept Has Changed
Over half a century ago, the ideal biomaterial was one that did absolutely nothing inside the body. Surgeons wanted metals and plastics that sat quietly, caused no reaction, and simply filled a structural role. Biocompatibility meant inertness: the less a material interacted with surrounding tissue, the better it was considered.
That thinking has shifted dramatically. Today’s biomaterials are often designed to actively participate in healing. Rather than avoiding interaction with the body, many modern materials deliberately trigger helpful biological responses: guiding stem cells toward bone formation, releasing anti-inflammatory signals, or dissolving on a controlled schedule once they’ve done their job. The current standard for biocompatibility, unchanged in its core wording for 40 years, is “the ability of a material to perform with an appropriate host response in a specific application.” What counts as “appropriate” has expanded from “no reaction at all” to “the right reaction at the right time.”
Natural vs. Synthetic Materials
Biomaterials fall into two broad camps: those borrowed from nature and those engineered from scratch.
Natural biomaterials include collagen (the protein that already makes up much of your connective tissue), chitosan (derived from the shells of crustaceans like shrimp and crabs), and silk fibroin (produced by silkworms). These materials have a built-in advantage: the body tends to recognize and tolerate them. Chitosan, for example, is used in wound dressings and in tissue-engineering scaffolds for skin, bone, cartilage, nerve, and blood vessel repair. Silk fibroin shows up in wound healing products and bone regeneration applications.
Synthetic biomaterials include metals, ceramics, and engineered polymers. Titanium alloys remain the workhorse for orthopedic and dental implants because they resist corrosion and bond well with bone. A high-performance polymer called PEEK has gained ground for spinal fusion cages because its stiffness closely matches human bone. Cortical bone has an elastic modulus of about 17.7 GPa, and PEEK sits at 8.3 GPa, while titanium alloy is far stiffer at 116 GPa. That mismatch matters: when an implant is much stiffer than the bone around it, it can shield the bone from normal mechanical stress and cause it to weaken over time. PEEK’s closer match reduces that risk.
What Makes a Material Biocompatible
Biocompatibility isn’t a single property you can measure with one test. It’s a judgment about whether a material performs safely in a specific location, for a specific duration, in a specific patient population. A material that works perfectly as a temporary skin patch might fail catastrophically as a permanent bone implant.
For metals, improving biocompatibility historically meant improving corrosion resistance so fewer metal ions leaked into surrounding tissue. For polymers, it meant designing molecular structures that resist absorbing water, breaking down, or releasing chemical additives. In both cases, the goal was reducing harmful byproducts.
The newer generation of “bioactive” materials flips this on its head. Instead of minimizing all biological interaction, these materials are engineered to beneficially direct interactions with the body. That can mean releasing ions that stimulate bone-forming cells, presenting surface textures at the nanoscale that encourage cell attachment, or even carrying molecules that steer immune cells toward a healing response rather than an inflammatory one.
Common Medical Applications
Biomaterials touch nearly every branch of medicine. In orthopedics, titanium plates, screws, and joint replacements have been standard for decades. PEEK spinal cages are now widely used in minimally invasive spinal fusion surgery for conditions like spinal stenosis. In cardiovascular medicine, stents are coated with bioactive layers (peptides, polymers, or composite systems) designed to reduce blood clot formation, inflammation, and the re-narrowing of arteries after a procedure.
Tissue engineering pushes biomaterials further. Here, a material serves as a temporary scaffold, a three-dimensional structure with carefully designed pores that cells can migrate into, attach to, and eventually replace with real tissue. For bone regeneration, pore size is critical. Studies typically report optimal ranges of 200 to 450 micrometers for bone growth under standard conditions, though research on 3D-printed ceramic scaffolds has shown that pores as large as 1,000 micrometers can significantly enhance early bone cell development when combined with active fluid flow that improves nutrient delivery. The most sophisticated scaffold designs now mimic natural bone by varying their structure across a single implant: denser, smaller-pore regions in areas that bear heavy loads, and more open, larger-pore regions where encouraging tissue ingrowth matters more.
Drug Delivery Systems
Some biomaterials are designed not as structural implants but as vehicles for delivering medication exactly where and when it’s needed. Hydrogels, which are water-rich polymer networks that resemble soft tissue, are a leading platform for this. They release drugs through a combination of mechanisms: the drug can slowly diffuse out through the gel’s pores, the gel can swell and open up its structure to let the drug escape, or the gel itself can gradually erode and dissolve, freeing the drug as it breaks down. By tuning the chemistry of the hydrogel, engineers can control which of these mechanisms dominates and how quickly the drug is released.
Smart Biomaterials That Respond to the Body
A growing class of biomaterials can sense and respond to conditions inside the body. These “stimuli-responsive” materials change their behavior when they detect shifts in acidity, temperature, enzyme activity, or other biological signals.
pH-responsive materials are especially useful for targeted drug release. Tumors and inflamed tissues tend to be more acidic than healthy tissue. A material engineered to degrade in acidic conditions can carry a drug through the bloodstream intact and release it only when it reaches the target site. One example: thermally sensitive capsules loaded with a chemotherapy drug that remain stable at normal body temperature but release their payload when the tumor region is externally heated to 40 to 45 degrees Celsius.
Enzyme-responsive materials take advantage of the fact that certain enzymes are overproduced at disease sites. Nanoparticles can be sealed with protein caps that are cleaved only by enzymes concentrated around a tumor, releasing anti-cancer drugs precisely where they’re needed and sparing healthy tissue from exposure.
How Biomaterials Are Tested for Safety
Before any biomaterial can be used in a medical device, it must pass a rigorous battery of biological safety evaluations outlined in international standards and enforced by agencies like the U.S. Food and Drug Administration. For a permanent implant intended to contact tissue or bone (anything staying in the body longer than 30 days), the required evaluations cover a wide range of potential harms:
- Cytotoxicity: whether the material kills or damages cells
- Sensitization: whether it triggers allergic reactions
- Irritation: whether it causes local inflammation
- Acute and chronic toxicity: whether it poisons the body in the short or long term
- Genotoxicity: whether it damages DNA
- Carcinogenicity: whether it increases cancer risk
- Implantation testing: how surrounding tissue actually responds to the material in place
For materials designed to break down inside the body, manufacturers must also provide detailed information about what the material degrades into and whether those breakdown products are safe. Novel materials face additional scrutiny for potential effects on reproductive health and fetal development. Every one of these safety endpoints must be addressed, either through new testing, existing data, or a documented rationale explaining why a particular test isn’t necessary for that specific device.